Anti-M?llerian Hormone Test Kit Market

Anti-M?llerian hormone (AMH) is a glycoprotein hormone produced by granulosa cells of small, growing follicles in the ovary. AMH serum concentrations decline over women?s reproductive lifespan, becoming undetectable approximately 5 years before menopause when the stock of primordial follicles is exhausted. Therefore, AMH has received increasing attention as a marker for ovarian reserves and has been shown to predict a woman?s reproductive potential.

AMH levels have become a useful fertility assessment tool that helps guide women?s fertility treatment and family planning decisions. AMH can also be used as a biomarker to diagnose polycystic ovary syndrome.

Anti-M?llerian Hormone Test Kit Market contains market size and forecasts of Anti-M?llerian Hormone Test Kit in global, including the following market information:

Global Anti-M?llerian Hormone Test Kit Market Revenue, 2017-2022, 2023-2028, ($ millions)

Global Anti-M?llerian Hormone Test Kit Market Sales, 2017-2022, 2023-2028, (K Units)

Global top five Anti-M?llerian Hormone Test Kit companies in 2021 (%)

The global Anti-M?llerian Hormone Test Kit market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period 2022-2028.

The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.

Human Use Segment to Reach $ Million by 2028, with a % CAGR in next six years.

The global key manufacturers of Anti-M?llerian Hormone Test Kit include Roche, Thermo Fisher Scientific, Eagle Biosciences, CTK Biotech, London Gynecology, Abbexa, LifeSpan BioSciences, Tecan and CUSABIO, etc. In 2021, the global top five players have a share approximately % in terms of revenue.

We surveyed the Anti-M?llerian Hormone Test Kit manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global Anti-M?llerian Hormone Test Kit Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (K Units)

Global Anti-M?llerian Hormone Test Kit Market Segment Percentages, by Type, 2021 (%)

Human Use

Animal Use

Global Anti-M?llerian Hormone Test Kit Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (K Units)

Global Anti-M?llerian Hormone Test Kit Market Segment Percentages, by Application, 2021 (%)

Household

Hospital & Clinic

Medical Laboratory

Others

Global Anti-M?llerian Hormone Test Kit Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (K Units)

Global Anti-M?llerian Hormone Test Kit Market Segment Percentages, By Region and Country, 2021 (%)

North America

US

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Nordic Countries

Benelux

Rest of Europe

Asia

China

Japan

South Korea

Southeast Asia

India

Rest of Asia

South America

Brazil

Argentina

Rest of South America

Middle East & Africa

Turkey

Israel

Saudi Arabia

UAE

Rest of Middle East & Africa

Competitor Analysis

The report also provides analysis of leading market participants including:

Key companies Anti-M?llerian Hormone Test Kit revenues in global market, 2017-2022 (Estimated), ($ millions)

Key companies Anti-M?llerian Hormone Test Kit revenues share in global market, 2021 (%)

Key companies Anti-M?llerian Hormone Test Kit sales in global market, 2017-2022 (Estimated), (K Units)

Key companies Anti-M?llerian Hormone Test Kit sales share in global market, 2021 (%)

Further, the report presents profiles of competitors in the market, key players include:

Roche

Thermo Fisher Scientific

Eagle Biosciences

CTK Biotech

London Gynecology

Abbexa

LifeSpan BioSciences

Tecan

CUSABIO

Zoomdoc

Bloom

myLAB Box

Hertility

CLOUD-CLONE

Global Diagnostics